Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-47.33	43.99	83.52
Graham Fair Price	41.24	25.29	17.91
PEG	-67.38	0.23	-0.70
Price/Book	8.63	3.79	3.49
Price/Cash Flow	-38.44	35.98	58.44
Prices/Earnings	-45.68	22.50	41.42
Price/Sales	-45.68	5.94	10.94
Price/FCF	-38.44	35.98	58.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.35	0.35
Operating Margin	-11.24	0.09	0.10
ROA	95.53	0.02	< 0.005
ROE	0.02	0.04	100.00
ROIC	0.01	0.03	80.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.10	-92.37
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.54	0.78	42.98
EPS QOQ	-0.59	0.98	66.54
FCF QOQ	30.26	0.76	-97.47
Revenue QOQ	-0.52	1.00	92.25
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	150.42	75.21	-50.00
Days Sales Outstanding (DSO)	67.47	39.29	-41.77
Inventory Turnover	0.60	1.20	100.00
Debt/Capitalization	0.41	0.40	-3.19
Quick Ratio	1.35	1.50	11.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	26.01	25.98	-0.13
Cash	2.82	2.81	-0.13
Capex	-0.51	-1.17	-129.72
Free Cash Flow	1.55	2.74	76.23
Revenue	8.30	16.57	99.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.89	2.88	-0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.03	5.95	-50.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating